Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 28, Issue 1, 2014, Pages 96-100

  Ye, Hui ^a   Bai, Xueli ^a   Gao, Hua ^a   Li, Li ^a   Wu, Chunxiao ^a   Sun, Xinping ^a   Zhang, Chunzhi ^a   Shen, Yajuan ^a   Zhang, Jian ^a   Lu, Zhiming ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Flow cytometry; Podocalyxin; Podocyte

Indexed keywords

CREATININE; CYSTATIN C; PODOCALYXIN; BIOLOGICAL MARKER; SIALOGLYCOPROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; URINALYSIS; AGED; ALBUMINURIA; BLOOD; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE COURSE; EARLY DIAGNOSIS; URINE;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; CYSTATIN C; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; SIALOGLYCOPROTEINS;

EID: 84891826816     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.08.006     Document Type: Article

References (23)

1. S.A. Aksun et al. Beta2-microglobulin and cystatin C in type 2 diabetes: Assessment of diabetic nephropathy Experimental and Clinical Endocrinology & Diabetes 112 4 2004 195 200
2. M.L. Caramori, P. Fioretto, and M. Mauer Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions Diabetes 52 4 2003 1036 1040
3. M.L. Caramori et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes Diabetes 51 2 2002 506 513
4. M. Dalla Vestra et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes Diabetes 52 4 2003 1031 1035
5. P. Habara et al. A novel method for the estimation of podocyte injury: Podocalyxin-positive elements in urine Folia Biol (Praha) 54 5 2008 162 167
6. P. Habara et al. Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of patients with glomerulonephritides - first promising results Folia Biol (Praha) 58 2 2012 57 63
7. M. Hara et al. Podocalyxin on the glomerular epithelial cells is preserved well in various glomerular diseases Nephron 67 1 1994 123 124
8. M. Hara et al. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis Nephron 69 4 1995 397 403
9. M. Hara et al. Immunohistochemical and urinary markers of podocyte injury Pediatric Nephrology 12 1 1998 43 48
10. M. Hara et al. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin Diabetologia 55 11 2012 2913 2919
11. Y.K. Jeon et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes Journal of Korean Medical Science 26 2 2011 258 263
12. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease American Journal of Kidney Diseases 49 2 Suppl 2 2007 S12 154
13. T. Nakamura et al. Urinary excretion of podocytes in patients with diabetic nephropathy Nephrology, Dialysis, Transplantation 15 9 2000 1379 1383
14. M.E. Pagtalunan et al. Podocyte loss and progressive glomerular injury in type II diabetes The Journal of Clinical Investigation 99 2 1997 342 348
15. A.T. Petermann et al. Viable podocytes detach in experimental diabetic nephropathy: Potential mechanism underlying glomerulosclerosis Nephron Experimental Nephrology 98 4 2004 e114 e123
16. A. Piwowar et al. Plasma cystatin C concentration in non-insulin- dependent diabetes mellitus: Relation with nephropathy Archivum Immunologiae et Therapiae Experimentalis 47 5 1999 327 331
17. E.I. Prodromidi et al. Bone marrowderived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of alport syndrome Stem Cells 24 11 2006 2448 2455
18. S.J. Shankland The podocyte's response to injury: Role in proteinuria and glomerulosclerosis Kidney International 69 12 2006 2131 2147
19. A. Shimizu et al. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy Journal of Clinical Laboratory Analysis 17 5 2003 164 167
20. Shimizu A Fau - Horikoshi, S., et al., Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. (0887-8013 (Print)).
21. E.J. Weil et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy Kidney International 82 9 2012 1010 1017
22. C.I. Whiteside et al. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis American Journal of Pathology 142 5 1993 1641 1653
23. D. Yu et al. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria Journal of the American Society of Nephrology 16 6 2005 1733 1741